Vir Biotechnology opens new $41M office in St. Louis

The San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis, opening a new $41 million office within the Cortex innovation district. It says the new facility will be critical to advancing research to treat several infectious diseases, including Covid-19.

Previous The Bezos Learning Center is coming to the Air and Space Museum. It might look like this.
Next Westin St. Francis hotel in San Francisco seeks $900M assessment cut